Skip to main content
OpenTrials

Clinical trial condition

Relapsed/Refractory T-cell Lymphomas

Explore clinical trials studying Relapsed/Refractory T-cell Lymphomas. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Relapsed/Refractory T-cell Lymphomas trial results

Completed

Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

NCT02783625

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Washington School of Medicine in St. Louis St Louis, Missouri, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions